Development
Development, from Pre-Clinical to Approval
Accelerate approval & launch readiness.
Shorten time to approval and move forward with the confidence that your non-clinical safety, regulatory and clinical strategies, CMC development, and supply-chain are compliant and aligned end-to-end.
The pre-approval phase is where the foundation of a product’s entire lifecycle is built. Decisions made early — on development strategy, regulatory pathway, CMC approach, non-clinical programme design and supply chain — shape everything that follows: timelines, costs, approval probability and long-term market viability.
Know More
Design and Construction
Engineer facilities and ensure GxP readiness.
Building a pharmaceutical or biotech facility is both a major commercial decision and a regulatory commitment. Every design choice, system specification and qualification protocol can directly affect GMP compliance, inspection readiness and eventual market supply.
PLG’s Engineering Centre of Excellence has delivered expert life sciences design and construction projects for over 20 years, spanning feasibility studies, detailed engineering, EPC/EPCM delivery and ongoing site maintenance.
Know More
Patient Access
From Approval to Access
Prove value & secure access.
We accelerate and optimize access to therapeutic innovation by combining global reach with deep local expertise, seamlessly integrating Market and Patient Access with cross-functional capabilities to support life sciences companies in navigating complexity, shaping policy, and delivering sustainable value to healthcare systems and patients.
A successful regulatory approval is a critical milestone, but it does not guarantee patient access to your product. In today’s environment, developing a comprehensive market access strategy is as demanding as the approval process itself. Payers, health technology assessment (HTA) bodies, and healthcare systems require robust evidence of clinical and economic value before granting reimbursement. Successful pricing and reimbursement strategies demand early planning, deep local knowledge, and the ability to operate across regulatory, scientific, commercial, and policy dimensions simultaneously.
Know More
Compliance
Regulatory, Safety & Quality
Ensure compliance and patient safety.
Ensuring access to products and patient safety across the lifecycle.
Receiving regulatory approval is a defining milestone — but it marks the beginning of a new set of obligations, not the end of the journey. Once a product is on the market, maintaining compliance, managing safety data, responding to regulatory changes and protecting supply continuity become ongoing priorities that require dedicated expertise and constant vigilance.
The post-approval landscape is increasingly complex. Regulatory authorities across global markets continue to raise the bar on pharmacovigilance, quality standards and lifecycle management requirements. A product change, a safety signal, a manufacturing variation or a new market expansion can each trigger a cascade of regulatory activity that demands a coordinated, experienced response.
Know More
Innovation
Data, Technology and Innovation
Complete, compliant, and innovative digital solutions to life sciences challenges.
While AI and digital developments promise to revolutionise the life sciences sector, practical application is often hindered by disconnected software systems, isolated data architectures, and stringent regulatory demands such as GxP frameworks and the European AI Act.
Many technology vendors lack the necessary industry and compliance experience, whilst standard consultancies often lack technical engineering depth. PLG bridges this gap by combining engineering proficiency with comprehensive regulatory and sector knowledge. We deploy operational, fully compliant digital solutions that turn technological potential into measurable corporate value.
Know More